Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor
Year: 2017
Type: review
Source: Drugs
Authors: Joleen M. Hubbard, Axel Grothey
Institution: Mayo Clinic
Language: English
Topic: Cancer Cells and Metastasis
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2621051455